SciELO - Scientific Electronic Library Online

 
vol.43 número3Deconstructing the myth of Pasewalk: Why Adolf Hitler’s psychiatric treatment at the end of World War I bears no relevance índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Archives of Clinical Psychiatry (São Paulo)

versão impressa ISSN 0101-6083versão On-line ISSN 1806-938X

Resumo

MARTINEZ-AGUAYO, Juan Carlos; ARANCIBIA, Marcelo; CONCHA, Sebastián  e  MADRID, Eva. Ten years after the FDA black box warning for antidepressant drugs: a critical narrative review. Arch. Clin. Psychiatry (São Paulo) [online]. 2016, vol.43, n.3, pp.60-66. ISSN 1806-938X.  http://dx.doi.org/10.1590/0101-60830000000086.

Background

The United States Food and Drug Administration (FDA) has warned about the increased suicidality risk associated with the use of selective serotonin reuptake inhibitors (SSRI) and venlafaxine in children and adolescents.

Objectives

To critically appraise the available evidence supporting the FDA Black box warning concerning to the use of antidepressants in child and adolescents.

Methods

A critical review of articles in Medline/PubMed and SciELO databases regarding the FDA Black box warning for antidepressants, and the impact of FDA warnings on antidepressant prescriptions and suicide rates.

Results

The warning was based on surveys that did not report either cases of suicide nor a significant difference supporting an increased suicidality rate. The concept was defined in an ambiguous way and there is currently more available evidence to support such definition. The use of SSRI and venlafaxine has been associated to lower suicidality rates, but the prescription fall due to the warning increased suicide rates.

Discussion

Suicidality is an inherent feature of depressive disorders so it would be desirable to consider how much of the phenomenon may be attributed to antidepressants per se. It would be appropriate to consider that suicide rates might increase also as a consequence of the warning.

Palavras-chave : Antidepressants; serotonin uptake inhibitors; suicide; United States Food and Drug Administration.

        · texto em Inglês     · Inglês ( pdf )